Schizophrenia
Scientists at Federal University detail research in schizophrenia
Published in Hospital Business Week, November 1st, 2009
In this recent report published in the journal Revista de Saude Publica, researchers in Florianopolis, Brazil conducted a study "To assess the cost-utility of first and second-generation antipsychotics for treatment of schizophrenia. A five-year Markov model was constructed based on a survey of the records of patients seen in 2006 at a psychosocial care center in the municipality of Florianopolis, Southern Brazil."
"Costs were evaluated from the perspective of the Sistema Unico de Sa de (SUS - Unified Healthcare System). Utility was measured in quality-adjusted life years obtained in the literature. The Markov model indicated risperidone and haloperidol...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- ACS
ACS Awarded Contract to Develop Health Information Exchange for the Commonwealth of Kentucky - Allina Hospitals & Clinics
The Minneapolis Heart Institute(R) at Abbott Northwestern Hospital and the American College of Cardiology Foundation present "The Miracle on Ice": Therapeutic Hypothermia for Cardiac Arrest Patients - Alpha Systems
Alpha Systems to Provide Electronic Document Management to Virtua - AseraCare
AseraCare Home Health Now Serving Atlanta - Aspyra, Inc.
Aspyra Enhances CyberLAB LIS with Added Data Sharing Capabilities - Autism
Experts Summarize State of the Science in Autism Disorders - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
